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Shiga toxins (Stxs) are expressed by the enteric pathogens Shigella dysenteriae serotype 1 and certain
serotypes of Escherichia coli. Stx-producing bacteria cause bloody diarrhea with the potential to progress to
acute renal failure. Stxs are potent protein synthesis inhibitors and are the primary virulence factors respon-
sible for renal damage that may follow diarrheal disease. We explored the use of the immortalized human
proximal tubule epithelial cell line HK-2 as an in vitro model of Stx-induced renal damage. We showed that
these cells express abundant membrane Gb3 and are differentially susceptible to the cytotoxic action of Stxs,
being more sensitive to Shiga toxin type 1 (Stx1) than to Stx2. At early time points (24 h), HK-2 cells were
significantly more sensitive to Stxs than Vero cells; however, by 72 h, Vero cell monolayers were completely
destroyed while some HK-2 cells survived toxin challenge, suggesting that a subpopulation of HK-2 cells are
relatively toxin resistant. Fluorescently labeled Stx1 B subunits localized to both lysosomal and endoplasmic
reticulum (ER) compartments in HK-2 cells, suggesting that differences in intracellular trafficking may play
a role in susceptibility to Stx-mediated cytotoxicity. Although proinflammatory cytokines were not upregulated
by toxin challenge, Stx2 selectively induced the expression of two chemokines, macrophage inflammatory
protein-1 (MIP-1) and MIP-1. Stx1 and Stx2 differentially activated components of the ER stress response
in HK-2 cells. Finally, we demonstrated significant poly(ADP-ribose) polymerase (PARP) cleavage after
exposure to Stx1 or Stx2. However, procaspase 3 cleavage was undetectable, suggesting that HK-2 cells may
undergo apoptosis in response to Stxs in a caspase 3-independent manner.
Shiga toxins (Stxs) are a family of genetically and function-
ally related cytotoxic proteins expressed by the enteric patho-
gens Shigella dysenteriae serotype 1 and certain serotypes of
Escherichia coli. Antigenic similarity to Shiga toxin expressed
by S. dysenteriae serotype 1 was used to define Shiga toxin type
1 (Stx1) and Stx2 expressed by Shiga toxin-producing E. coli
(STEC) (47). Cloning and sequencing of the toxin genes re-
vealed that Stx1 differs from the prototypical Shiga toxin by 1
amino acid, while Stx2 shares 56% sequence homology at the
deduced amino acid sequence level with Shiga toxin and Stx1
(21, 46). Stxs are AB5 toxins, consisting of a single A subunit in
noncovalent association with 5 B subunits that form a penta-
meric ring. B subunits are responsible for binding to target
cells, while the A subunit is responsible for protein synthesis
inhibition (43). The toxin receptor is the neutral globo series
glycolipid globotriaosylceramide (Gb3), although one Stx2
variant toxin (Stx2e) has been shown to be capable of binding
globotetraosylceramide (Gb4) (9). Following internalization,
the toxins undergo retrograde transport, which delivers the
toxins to the endoplasmic reticulum (ER). A fragment of the A
subunit is cleaved from the holotoxin by furin or a furin-like
protease during retrograde transport. This fragment, termed
the A1 fragment, is translocated across the ER membrane
using the Sec61 translocon and enters the cytosol, where it
cleaves a single adenine residue from the 28S rRNA compo-
nent of eukaryotic ribosomes (22, 33, 44). Stx-induced depuri-
nation leads to protein synthesis inhibition by disrupting elon-
gation factor-dependent aminoacyl-tRNA binding to nascent
polypeptides (36). Stxs have also been shown to activate host
cell signaling pathways, including the ribotoxic stress response
and ER stress pathways. Activation of these intracellular sig-
naling cascades may be important for proinflammatory cyto-
kine/chemokine production and apoptosis induction in some
cell types (7, 31, 45).
Ingestion of Stx-producing bacteria may lead to the devel-
opment of bloody diarrhea and, in some cases, progression to
acute renal failure, termed diarrhea-associated hemolytic ure-
mic syndrome (DHUS) (38). DHUS, a leading cause of
pediatric acute renal failure, is characterized by rapid-onset
oligouria or anuria, azotemia, microangiopathic hemolytic ane-
mia with schistocytosis, and thrombocytopenia (38, 49). Histo-
pathological examination of DHUS renal tissues showed that
glomerular microvascular endothelial cells were frequently
swollen and detached from the basement membrane and glo-
merular capillary lumina were occluded with fibrin-rich micro-
thrombi (28, 40). Glomerular endothelial cells are not the only
targets damaged by Stxs in the kidney. Immunohistochemical
and immunofluorescence staining techniques used on murine,
baboon, and human kidney sections showed that renal tubules
were rich in Gb3, and toxin overlay studies showed that Stxs
bound to renal tubules (32, 51, 52). Primary human proximal
tubule cells express high levels of membrane Gb3 and are
highly sensitive to Stx cytotoxicity in vitro (17, 26, 27). Karpman
et al. (23) noted that cell damage in renal biopsy specimens
from pediatric DHUS cases and in mice fed an Stx2-produc-
ing STEC strain was localized to the renal cortex, with patho-
logical changes detected in both glomerular endothelial and
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tubular epithelial cells. Clinical studies using pediatric and
geriatric renal biopsy specimens isolated from DHUS cases
detected the presence of Stx1 and Stx2 within renal tubules (6,
54). Finally, urinary excretion of markers of proximal tubular
damage, such as N-acetyl glucosaminidase and 2-microglobu-
lin, are elevated early in the course of DHUS, suggesting that
Stx-mediated renal tubular damage may precede damage to
glomerular endothelial cells (48). Collectively, these data
suggest that proximal tubules may be an important early
target of the toxins and that damage to renal tubules may
contribute to the progression of disease leading to glomer-
ular damage and the signs and symptoms of DHUS.
Cell culture of primary and immortalized cells has been
helpful in understanding the role single cell types play in renal
function, pathology, and regeneration. Ryan et al. (42) created
an immortalized adult human proximal tubule epithelial cell
line designated human kidney 2 (HK-2). This cell line, trans-
formed using the human papillomavirus type 16 (HPV16)
E6/E7 genes, maintains proximal tubule epithelial morphol-
ogy. The goal of the present study was to characterize HK-2
cells as a suitable model to study Stx-mediated renal damage
and the host response to Stx1 and Stx2. We show that HK-2
cells express high levels of membrane Gb3 and are differen-
tially susceptible to the cytotoxic action of Stx1 and Stx2. HK-2
cells traffic labeled Stx1 B subunits to both the lysosomal and
ER compartments. Stx2 uniquely induced the expression of
two chemokines, macrophage inflammatory protein 1 (MIP-
1/CCL3) and MIP-1/CCL4. Stx1 and Stx2 differentially ac-
tivate components of the ER stress response in HK-2 cells.
Finally, Stxs appear to induce apoptosis in HK-2 cells by acti-
vating poly(ADP-ribose) polymerase (PARP) cleavage in a
caspase 3-independent manner.
MATERIALS AND METHODS
Cell culture. The HK-2 cell line and Vero cells, an African green monkey renal
epithelial cell line, were purchased from the American Type Culture Collection
(Manassas, VA). HK-2 cells were maintained in complete medium consisting of
keratinocyte–serum-free medium (K-SFM) supplemented with bovine pituitary
extract (BPE), human recombinant epidermal growth factor (EGF) (Invitrogen,
Carlsbad, CA), penicillin (100 U/ml), and streptomycin (100 g/ml) (Gibco-
BRL, Grand Island, NY) at 37°C in 5% CO2 in a humidified incubator. The Vero
cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) (Gibco-
BRL, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS)
(HyClone Laboratories, Logan, UT), penicillin (100 U/ml), and streptomycin
(100 g/ml) at 37°C in humidified 5% CO2.
Toxins. Stx1 was prepared as previously described (51). Briefly, Stx1 was
purified from cell lysates prepared from E. coli DH5(pCKS112) by sequential
ion exchange and chromatofocusing chromatography. The purity of toxin prep-
arations was assessed by sodium dodecyl sulfate-polyacrylamide gel electropho-
resis (SDS-PAGE) with silver staining and Western blot analysis with anti-Stx1
antibodies. Toxin preparations contained 0.1 ng of endotoxin per ml, as de-
termined by the Limulus amoebocyte lysate assay (Associates of Cape Cod,
Falmouth, ME). Recombinant Stx2 was obtained through the NIAID, NIH
Biodefense and Emerging Infections Research Resources Repository (BEI Re-
sources) (Manassas, VA). Purified pentameric Stx1 B subunits were a kind gift
from Cheleste Thorpe, Tufts University School of Medicine, Boston, MA.
Gb3 quantification. HK-2 cells (5.0 105 cells) were placed in microcentrifuge
tubes in 300 l complete medium. Stxs bind to Gb3 at 4°C; therefore, all subse-
quent steps were done on ice to prevent receptor internalization. Stx1 B subunits
(1.2 mg/ml) were added to the cells and incubated for 1 h with gentle shaking.
The cells were then centrifuged and washed twice with cold PBS. The cells were
resuspended in a 1:100 dilution of anti-Stx1 B subunit murine monoclonal anti-
body (13C4; Hycult Biotech Inc., Plymouth Meeting, PA) for 30 min. After
incubation, the cells were centrifuged and washed twice with PBS. Finally, the
cells were resuspended in a 1:50 dilution of fluorescein-conjugated horse anti-
mouse IgG antibody (Vector Laboratories Inc., Burlingame, CA) for 30 min. The
cells were washed in PBS and analyzed by flow cytometry (FACSAria; BD
Bioscience, San Jose, CA). Fluorescence parameters were gated using stained
and unstained untreated cells. At least 104 events were measured for each
sample.
Cytotoxicity assay. Vero or HK-2 cells (5.0  104 cells per well) were plated
in 96-well plates and grown to 80% confluence at 37°C. The cells were exposed
to various concentrations of Stx1 or Stx2, ranging from 100 fg/ml to 1.0 mg/ml.
After incubation at 37°C in 5% CO2 for 24, 48, or 72 h, 25 l of 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) solution (5.0 mg/ml) was
added to each well and incubated for 2 h at 37°C in a 5% CO2 humidified
incubator. After incubation, the plates were centrifuged for 5 min. The super-
natants were removed, and 100 l of lysis buffer (20% SDS, 50% 2-2-dimethyl-
formamide [pH 4.7]) was added to each well. The plates were incubated at 37°C
for 3 h. Optical densities (OD) were measured in an automated plate reader
(Dynatech MR5000; Molecular Dynamics, Chantilly, VA). The percent cell
survival was calculated as follows: [(average OD570 {OD at 570 nm} of treated
cells  average OD570 of untreated control cells)/average OD570 of untreated
control cells]  100. Statistical significance was assessed using a t test in Graph-
pad Prism version 5 (Graphpad Software, La Jolla, CA).
Intracellular toxin trafficking. Intracellular trafficking of Stxs into HK-2 cells
was determined using purified Stx1 B subunits conjugated to a fluorescent tag
(Stx1 B-Alexa 488). Fifty micrograms of purified Stx1 B subunits was labeled
using Alexa Fluor-488 Microscale Kits (Molecular Probes Inc., Invitrogen, Eu-
gene, OR) as described in the manufacturer’s protocol. Briefly, HK-2 cells (1.0
105 cells/well) were seeded overnight in four-well Lab-Tek chambered borosili-
cate cover glass slides (Nalge-Nunc International, Rochester, NY). The cells
were washed two times with complete medium before further staining for 30 min
at 37°C with cell-permeable-lysosome- or endoplasmic-reticulum-specific dye
(100 nM Lyso-Tracker or 60 nM ER-Tracker live-cell staining dye; Molecular
Probes Inc., Invitrogen, Eugene, OR). Complete medium containing 100 ng/ml
Stx1 B-Alexa 488 was added to the cell monolayers. The cells were washed
extensively and then imaged over the next 5 to 90 min. Single confocal optical
sections through the middle of the majority of cells in the field of view were taken
simultaneously for the red, blue, and green emission channels using a Stallion
Digital Imaging Station (Carl Zeiss Microscopes, Gottingen, Germany) and
SlideBook 4.2 image software (Olympus America Inc., Center Valley, PA). The
images are representative of two independent experiments. All data within each
experiment were collected at identical settings.
Real-time reverse transcription (RT)-PCR. HK-2 cells were exposed to either
75 pg/ml Stx1 or Stx2 for 15, 30, 60, 120, or 240 min. Total RNA was isolated
using TRIzol Plus kits with an RNase-free DNase treatment (Invitrogen, Carls-
bad, CA) according to the manufacturer’s instructions. RNA was reverse tran-
scribed to cDNA using a high-capacity cDNA reverse transcription kit (Applied
Biosystems, Carlsbad, CA), and real-time PCR was performed on the resulting
cDNAs using SYBR green I double-stranded DNA binding dye (Applied Bio-
systems, Carlsbad, CA). The following real-time primers were used: tumor ne-
crosis factor alpha (TNF-), F (5-CCAGGCAGTCAGATCATCTTCTC-3)
and R (5-AGCTGGTTATCTCTAGCTCCAC-3); interleukin 1 (IL-1), F
(5-TCCCCAGCCCTTTTGTTGA-3) and R (5-TTAGAACCAAATGTGGC
CGTG-3); IL-8, F (5-AAGGAACCATCTCACTGTGTGTAAAC-3) and R
(5-ATCAGGAAGGCTGCCAAGAG-3); MIP-1, F (5-TTGTGATTGTTTG
CTCTGAGAGTTC-3) and R (5-CGGTCGTCACCAGACACACT-5); MIP-
1, F (5-CCCTGGCCTTTCCTTTCAGT-3) and R (5-AGCTTCCTCGCGG
TGTAAGA-3); and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), F
(5-CAACGGATTTGGTCGTATTGG-3) and R (5-GGCAACAATATCCAC
TTTACCAGAGT-3).
Real-time PCRs were carried out with 100 nM concentrations (each) of for-
ward and reverse primers in a final volume of 25 l. To control for the presence
of contaminating DNA, reverse transcriptase-negative reaction mixtures were
included. Nontemplate controls were run to test for DNA-contaminated primers.
Real-time reactions were run and analyzed by using an ABI Prism 7500 sequence
detection system (Applied Biosystems, Carlsbad, CA). Dissociation curves for
PCR samples were made to guarantee amplification of the correct genes. The
amount of mRNA, expressed as fold change, was determined from the change in
threshold cycle (CT) values normalized for GAPDH expression and then nor-
malized to the value derived from cells at time zero prior to medium change or
treatment. Statistical analyses of real-time PCR data were performed using 	CT
values. Statistical significance was assessed at a P value of 0.05 by one-way
analysis of variance (ANOVA) with Dunnett’s posttest using Graphpad Prism
version 5 (Graphpad Software, La Jolla, CA).
Measurement of cytokine and chemokine production. HK-2 cells were treated
with 75 pg/ml Stx1 or Stx2 for 15, 30, 60, 120, or 240 min. The cellular superna-
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tants were collected and stored at 80°C until they were analyzed. The Bio-Plex
Pro Human Cytokine Standard Group 1 27-Plex kit was purchased from Bio-Rad
Laboratories (Hercules, CA) and used according to the manufacturer’s instruc-
tions. A series of eight standards ranging in concentration from 1.95 to 32,000
pg/ml was included in each assay. Samples from three independent experiments
were analyzed in triplicate and graphed using GraphPad Prism. The data are
expressed as means of fold induction 
 standard errors of the mean (SEM).
Statistical significance was assessed at a P value of 0.05 by one-way ANOVA
with Dunnett’s posttest using Graphpad Prism version 5 (Graphpad Software, La
Jolla, CA).
Western blot analysis. HK-2 cells were treated with 75 pg/ml Stx1 or Stx2, 100
M thapsigargin (ER stress positive control), or 100 M doxorubicin HCl (apop-
tosis positive control) for various times. Cells were harvested and lysed at 4°C in
modified radioimmunoprecipitation assay (RIPA) buffer (1.0% Nonidet P-40,
1.0% sodium deoxycholate, 150 nM NaCl, 50 nM Tris-HCl [pH 7.5], 0.25 mM
sodium pyrophosphate, sodium vanadate, and sodium fluoride [2.0 mM each], 10
mg of aprotinin/ml, 1.0 mg of leupeptin and pepstatin/ml, and 200 mM phenyl-
methylsulfonyl fluoride). Extracts were collected and cleared by centrifugation at
15,000  g for 10 min, and the protein concentration was determined using the
DC Protein Assay kit (Bio-Rad). Equal amounts of protein (100 g per lane)
were separated by SDS-PAGE using 4 to 20% acrylamide gels and transferred to
nitrocellulose membranes, which were blocked with 5% nonfat milk prepared in
Tris-buffered saline (TBS)-Tween 20 (200 mM Tris [pH 7.6], 1.38 M NaCl, 0.1%
Tween 20) and incubated overnight at 4°C with primary antibodies specific for
phospho-IRE1 (Novus Biologicals, Littleton, CO), ATF-6, phospho-PERK, total
PERK, BiP, CCAAT/enhancer-binding protein (C/EBP) homologous protein
(CHOP), PARP, caspase 3, caspase 8, and actin (Cell Signaling Technology, Inc.,
Danvers, MA) in 5% bovine serum albumin made with TBS-0.1% Tween 20. The
membranes were then incubated with secondary antibodies (horseradish perox-
idase-labeled anti-rabbit or anti-mouse antibodies; Cell Signaling Technology,
Inc., Danvers, MA) for 1 h at room temperature. Bands were visualized using the
Western Lightning Chemiluminescence System (NEN-Perkin Elmer, Boston,
MA). The intensities of the protein bands captured on autoradiography film were
quantified using Image J software (NIH, Bethesda, MD). The fold induction was
calculated as treated protein band intensity values divided by untreated control
protein band intensity values after normalizing for loading controls. The data
shown are from at least three independent experiments. Statistical significance
was assessed at a P value of 0.05 by one-way ANOVA with Dunnett’s posttest
using Graphpad Prism version 5 (Graphpad Software, La Jolla, CA).
RESULTS
HK-2 cells maintain high levels of membrane-associated
toxin receptor expression. Renal tubular epithelial cells may be
targets of Stxs early in disease progression. Gb3 is the sole
receptor characterized for all Stxs causing DHUS, and stud-
ies designed to examine renal Gb3 expression in situ have
shown that renal tubules express abundant Gb3. Therefore,
using an indirect immunofluorescence assay and flow cytom-
etry, we examined Gb3 expression by HK-2 cells (Fig. 1). It was
determined that 95.6% 
 0.8% of the gated HK-2 cell popu-
lation expressed Gb3 on their surfaces. Gb3 was not detected
on cells treated with an isotype-matched primary antibody
(isotype control; 1.1% 
 0.8%). These data suggest that, in
keeping with studies examining renal Gb3 expression, HK-2
cells maintain high membrane expression of the Stx receptor in
vitro.
HK-2 cells are differentially sensitive to killing by Stx1 and
Stx2. While primary human renal epithelial cells are sensitive
to the cytotoxic effects of Stxs in vitro, Stx2 is more likely to
lead to life-threatening extraintestinal complications. There-
fore, we compared the cytotoxic effects of Stx1 and Stx2 on
HK-2 cells. The cells were exposed to various concentrations of
Stx1 or Stx2 for 3 different times (Fig. 2). The percent cell
survival following toxin treatments was calculated in compari-
son to untreated control cells. Both Stx1 and Stx2 killed HK-2
cells in a dose-dependent fashion over the monitored time
course; however, we noted significant differences in the kinet-
ics and extents of cell death caused by the toxins at the various
toxin concentrations. Treatment with Stx1 resulted in a more
rapid onset of cell death than treatment with Stx2, with 35%
and 58% of cells surviving following 24-h treatment with the
FIG. 1. Analysis of Gb3 expression on the surfaces of HK-2 cells. HK-2 cells were treated with Stx1 B subunits on ice for 1 h. The cells were
subsequently washed and incubated with 13C4, an anti-Stx1 monoclonal antibody, on ice for 30 min. After centrifugation, the cells were washed
and incubated with fluorescein isothiocyanate (FITC)-conjugated anti-mouse IgG antibody for 30 min. After washing, the cells were subjected to
fluorescence-activated cell sorter (FACS) analysis for membrane Gb3 expression. The data shown are the means 
 SEM for three independent
experiments.
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lowest dose (100 fg/ml) of either Stx1 or Stx2, respectively (Fig.
2A). With the toxin dose range used in this comparative study,
cell viability did not appear to significantly change over time in
response to Stx1, with cell survival remaining at or below 40%
at all three time points. HK-2 cells were significantly less sen-
sitive to Stx2 than to Stx1, as evidenced by reduced cell killing
at all time points examined (Fig. 2A to C). The estimated 50%
cytotoxic dose (CD50) values for HK-2 cells treated with Stx1
or Stx2 are shown in Table 1.
Vero cells are used because they are highly sensitive to the
cytotoxic action of Stxs. Therefore, using the viability indicator
dye MTT, we compared the sensitivities of HK-2 cells and
Vero cells to both Stx1 and Stx2 (Fig. 3). The percent cell
survival following toxin treatments was calculated in compari-
son to untreated control cells. Both Vero and HK-2 cells re-
sponded to Stx1 and Stx2 in a dose-dependent manner at all
monitored time points. The estimated CD50 for Vero cells
exposed to Stx1 at the 24-h time point is 800 pg/ml, and the
CD50 for HK-2 cells is 100 fg/ml at the same time point
(Table 1). We did not achieve 50% cytotoxicity in Vero cells
treated with Stx2 at 24 h with the chosen dose range; however,
the estimated CD50 for HK-2 cells at this time point is 300
pg/ml (Table 1). Vero and HK-2 cells are similarly sensitive to
Stx1 and Stx2 48 h after exposure; however, Stx1 appears to be
more cytotoxic than Stx2 for both cell types (Fig. 3C and D).
Despite HK-2 cells appearing to be more sensitive to the toxins
at 24 h, by 72 h, Vero cells are highly sensitive to Stx1 and Stx2,
with both toxins killing 100% of the Vero cells at all monitored
doses. In contrast, a subset of HK-2 cells appears to have
survived the cytotoxic effect, particularly the effect of low doses
of Stx2 (Fig. 3E and F). Although we have not characterized
the HK-2 cell subpopulation that survived toxin exposure,
given the high replication rate of HK-2 cells in complete me-
dium, the most likely explanation for increases in percent cell
survival over time following Stx2 exposure is replication of cells
that survived toxin challenge.
FIG. 2. Cytotoxic effects of Stx1 and Stx2 on HK-2 cells. HK-2 cells (5  104 cells per well) were incubated with different concentrations of
either Stx1 or Stx2, as indicated. After incubation for 24 h (A), 48 h (B), or 72 h (C), viable-cell numbers were estimated by MTT assay. The graphs
depict percent cell viability compared to untreated cells and represent the means 
 SEM of three independent experiments. The asterisks denote
significant differences between cells stimulated with Stx1 and Stx2 (*, P  0.05; **, P  0.01).
TABLE 1. CD50 values for HK-2 and Vero cells
Time (h)
CD50
HK-2 cells Vero cells
Stx1 Stx2 Stx1 Stx2
24 100 fg/ml 300 fg/ml 800 pg/ml 100 ng/ml
48 100 fg/ml 6 pg/ml 300 fg/ml 2 ng/ml
72 100 fg/ml 20 pg/ml 100 fg/ml 100 fg/ml
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Shiga toxin B subunits translocate to lysosomal and ER
compartments in HK-2 cells. Following binding to Gb3, Stxs
enter cells via receptor-mediated endocytosis and utilize ret-
rograde transport to access the ER lumen (44). To study the
intracellular routing of Stxs in HK-2 cells, we used confocal
fluorescence microscopy with fluorescently labeled Stx1 B sub-
units (Fig. 4). Cells were stained with Lyso-Tracker (red) or
ER-Tracker (blue) live-cell-staining dyes and subsequently ex-
posed to Stx1 B subunits conjugated with Alexa 488 (green) for
the indicated times. Stx1 B subunits rapidly trafficked to both
FIG. 3. Cytotoxic response of Vero cells to Stx1 or Stx2 versus that of HK-2 cells. Vero or HK-2 cells (5  104 cells per well) were incubated
with different concentrations of either Stx1 or Stx2, as indicated. After incubation for 24 h (A and B), 48 h (C and D), or 72 h (E and F), viable-cell
numbers were estimated by MTT assay. The graphs depict percent cell viability compared to untreated cells and represent the means 
 SEM of
three independent experiments. Vero cell and HK-2 cell cytotoxicities are denoted by solid lines and dashed lines, respectively. The asterisks
denote significant differences between Vero and HK-2 cells (*, P  0.05; **, P  0.01).
VOL. 79, 2011 RESPONSE OF HK-2 CELLS TO SHIGA TOXIN TYPES 1 AND 2 3531
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
lysosomal and ER compartments. Toxin was routed to the
lysosome of HK-2 cells within 4 min, as indicated by the colo-
calization of the red and green dyes in merged images, pro-
ducing yellow fluorescence. Simultaneously, Stx1 B subunits
were routed to the ER compartments of HK-2 cells, as indi-
cated by the light-blue fluorescence formed by blue and green
dyes in merged images. Stx1 B subunit routing to the ER was
noted as early as 4 min after treatment, and maximal ER
localization was noted 60 min after Stx1 B subunit exposure.
Use of fluorescently labeled Stx2 B subunits yielded similar
trafficking data within HK-2 cells (data not shown). The sen-
sitivity of HK-2 cells to Stxs may correlate with efficient intra-
cellular routing to the ER. The observation that some portion
of internalized toxin B subunits were routed to HK-2 cell
lysosomes suggests that some cells may be able to survive toxin
exposure by diverting greater amounts of internalized toxins
into the lysosomal degradation pathway.
Cytokine and chemokine expression elicited by Stx1 and
Stx2 treatment of HK-2 cells. Stxs trigger the release of cyto-
kines and chemokines from epithelial and myeloid cells. To
better understand the response of HK-2 cells to Stxs, we ana-
lyzed the expression of the proinflammatory cytokines TNF-
and IL-1 and the chemokines IL-8 (CXCL8), MIP-1
(CCL3), and MIP-1 (CCL4) at both the mRNA and protein
levels (Fig. 5). Stx1 treatment elicited a modest and delayed
increase in TNF- mRNA expression, peaking at 6-fold in-
crease 4 h after toxin exposure. In contrast, Stx2 treatment
induced a rapid increase in TNF- mRNA (200-fold) de-
tected 15 min after toxin exposure. TNF- mRNA levels then
declined by 30 min and began to increase to levels 100-fold
higher than those in control cells by 120 min. It is important to
note that in the presence of growth factors in complete me-
dium (see Materials and Methods), HK-2 cells expressed high
basal levels of cytokine and chemokine proteins. Despite basal
levels of TNF- protein expression and despite the capacity of
the toxins to increase TNF- mRNA production, neither Stx1
nor Stx2 induced the expression of TNF- protein above un-
treated-control levels (Fig. 5A). There was an increase in the
fold induction of IL-1 mRNA with both Stx1 and Stx2 treat-
ments. Similar to the TNF- transcriptional response, Stx1
minimally induced IL-1 transcripts, peaking at 5-fold by 90
min, while Stx2 induced a maximal 4,000-fold increase in
IL-1 transcripts 30 min after treatment. Despite the detection
of IL-1 transcripts after treatment with Stx1 and Stx2, IL-1
protein was not detected in cell supernatants, including un-
treated control cells (Fig. 5B).
Neutrophils have been reported to play a role in the devel-
opment of DHUS (5). Therefore, we examined the ability of
HK-2 cells to produce the major neutrophil chemoattractant
IL-8 after exposure to Stx1 or Stx2. Stx1 did not elicit IL-8
mRNA or protein from HK-2 cells above untreated-control
levels. In contrast, Stx2 triggered a 40-fold increase in IL-8
mRNA at 30 min, but protein levels were reduced relative to
untreated controls (Fig. 5C). MIP-1 and MIP-1 are che-
moattractants that primarily recruit macrophages to sites of
infection and may play an important role in the pathogenesis of
DHUS (25). Therefore, we examined the ability of HK-2 cells
to produce MIP-1 and MIP-1 in response to Stx1 or Stx2.
Stx1 was unable to generate MIP-1 or MIP-1 mRNA above
control levels. In Stx1-treated cells, MIP-1 and MIP-1 pro-
teins were reduced compared to untreated controls. In contrast
to Stx1, Stx2 exposure triggered the upregulation of MIP-1
and MIP-1 at both the mRNA and protein levels (Fig. 5D and
E). Thus, Stx2 appeared to be uniquely capable of upregulating
the production and release of MIP-1 and MIP-1 by HK-2
cells in vitro. The upregulation of MIP-1 and MIP-1 may
facilitate the recruitment of macrophages and neutrophils into
sites of renal tubular damage and further exacerbate tissue
damage.
The ER stress response is differentially induced after Stx1
or Stx2 exposure in HK-2 cells. The unfolded-protein response
(UPR) is a “quality control” mechanism that has evolved to
FIG. 4. Stx1 B subunit-Alexa 488 trafficking in HK-2 cells. HK-2 cells were treated with 100 nM Lyso-Tracker (red) or 60 nM ER-Tracker (blue)
live-cell-staining dyes for detection of the lysosomal compartment and endoplasmic reticulum, respectively. Subsequently, the cells were stimulated
with complete medium containing 100 ng/ml Stx1 B-Alexa 488 (green) for the indicated times. A single confocal optical section through the middle
of the majority of cells in the field of view was taken for red, blue, and green emission channels simultaneously using a Stallion Digital imaging
station. The presence of yellow or light-blue fluorescence in the merged images indicates toxin colocalization. The images are representative of
two independent experiments. All data within each experiment were collected at identical settings.
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FIG. 5. Cytokine and chemokine production elicited by Stx1 and Stx2 treatment of HK-2 cells. HK-2 cells were stimulated with 75 pg/ml
of either Stx1 or Stx2 for 15, 30, 60, 120, or 240 min. Total RNA was isolated, DNase treated, and cDNA synthesized. Quantitative real-time
PCR was performed with primers specific for TNF- (A), IL-1 (B), IL-8 (C), MIP-1 (D), MIP-1 (E), and the internal control GAPDH.
Relative expression was calculated using the 	CT method and expressed as fold change relative to untreated-control levels (gray bars). The
data were derived from at least two independent experiments. Cell supernatants were collected and analyzed for TNF-, IL-1, IL-8,
MIP-1, and MIP-1 proteins as described in Materials and Methods (black bars). The data shown are the mean fold change 
 SEM derived
from three independent experiments. Statistical significance was calculated using one-way ANOVA (*, P  0.05; **, P  0.01; ***, P 
0.001).
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detect the presence of unfolded or misfolded proteins within
the ER lumen (10, 20). Failure to correct protein folding and
restore normal anterograde protein transport/secretion path-
ways leads to ER stress or prolonged signaling through the
UPR and the initiation of apoptosis (4, 39). Three sensors
located within the ER membrane detect the presence of un-
folded proteins: the transcription factor ATF6, the protein
kinase/endoribonuclease IRE1, and the protein kinase PERK.
Activation of these sensors by proteolytic cleavage (ATF6) or
phosphorylation (IRE1 and PERK) alters gene expression, in
part by upregulating the expression of the transcriptional fac-
tor CHOP, which positively regulates the expression of chap-
erone genes and negatively regulates the antiapoptotic protein
Bcl-2 (2). To investigate whether Stx1 and Stx2 exposure trig-
gers the ER stress response in HK-2 cells, we analyzed ATF6,
IRE1, and PERK activation by Western blot analyses. In the
presence of Stx1, cleavage of ATF6 peaked (5-fold) 2 h after
toxin stimulation but returned to basal levels within 12 h.
Unlike Stx1, the transcription factor ATF6 was not significantly
cleaved in response to Stx2 over the monitored period (Fig. 6A
and C). We did not detect a significant change in the phos-
phorylation of PERK or IRE1 sensors throughout the moni-
tored time course following treatment of HK-2 cells with Stx1.
Stx2 elevated both PERK and IRE1 phosphorylation after
toxin exposure. Phospho-PERK levels began to rise 2 h after
Stx2 exposure with maximal signal detected at 24 h (3-fold
induction; P  0.001). Levels of phospho-IRE1 peaked 1 h
after exposure (3-fold induction; P  0.05) and returned to
basal levels by 24 h (Fig. 6B and D). Using thapsigargin as a
positive inducer of the ER stress sensors phospho-IRE1 and
ATF6, we found a 3.6-fold increase in the phosphorylation of
IRE1 and a 1.6-fold increase in ATF-6 proteolysis (data not
shown). Thus, Stx1 and Stx2 appear to activate nonoverlapping
components of the ER stress response in HK-2 cells.
BiP is the major chaperone present in the ER lumen in-
volved in the detection of misfolded proteins. BiP dissociates
from the luminal portion of ATF6, IRE1, and PERK to bind
misfolded proteins (20). Signaling through UPR sensors up-
FIG. 6. UPR sensors are differentially activated after Stx1 or Stx2 exposure in HK-2 cells. (A and B) HK-2 cells were stimulated with 75 pg/ml
Stx1 or Stx2, and at the indicated time points, cells were lysed and whole-cell lysates (100 g/well) were subjected to SDS-PAGE (4% to 20%) and
probed using antibodies specific for the activated forms of the UPR signaling molecules ATF6 (50 kDa) (A), phospho-PERK (170 kDa) (B), and
phospho-IRE1 (110 kDa). The blots shown are characteristic of at least three independent experiments. (C and D) Mean densitometric readings
of Western blot band intensities from three independent experiments. The data are expressed as means plus SEM; statistical significance was
calculated using one-way ANOVA (*, P  0.05; ***, P  0.001) compared to control untreated cells.
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regulates the expression of BiP. To examine the functionality
of ER stress triggered by Stx1 and Stx2 in HK-2 cells, we
assessed the effect of toxin treatment on BiP expression. Stx1
significantly upregulated BiP protein levels. Fifteen minutes
after exposure to Stx1, HK-2 cells had3-fold induction in BiP
protein levels, which returned to basal levels within 4 h (Fig.
7A). We did not detect significant increases in BiP protein
levels following Stx2 treatment, even when the time course was
extended to 6 h. The UPR also increases expression of the
transcription factor CHOP (2). We therefore investigated the
effects of Stx1 and Stx2 on CHOP protein levels expressed by
HK-2 cells. CHOP protein levels showed maximal increase 60
min after intoxication with Stx1, peaking at 9-fold increase
compared to untreated control cells (Fig. 7B). Stx2 treatment
did not upregulate CHOP expression to the same extent as
Stx1, as maximal fold induction peaked at 2.1 
 0.1. CHOP
expression induced by Stx2 treatment was significantly upregu-
lated compared to untreated control cells. Collectively, these
data suggest that Stx1 and Stx2 differentially induce the ER
stress response in HK-2 cells.
Stx1 and Stx2 treatment induces caspase 3-independent
PARP cleavage. Stx1 and Stx2 treatment of HK-2 cells induced
PARP cleavage, although Stx1 cleaved PARP more quickly
and to a greater extent than Stx2 (Fig. 8A and B). The rapid
activation of caspase 8 and 3 has emerged as a key element in
Stx-induced apoptosis (30), and PARP is a known substrate of
caspase 3 (53). Therefore, we examined the effect of Stx1 or
Stx2 treatment on the activation of caspase 3 and 8 in HK-2
cells. We were unable to detect procaspase 3 cleavage follow-
ing treatment of HK-2 cells with either Stx1 or Stx2 throughout
the monitored time course (Fig. 8A). Doxorubicin HCl, a pos-
itive control for procaspase 3 cleavage, showed a 3-fold in-
crease in cleaved caspase 3 levels over untreated-control levels
(Fig. 8C). Treatment of HK-2 cells with Stx1 did not signifi-
cantly cleave procaspase 8 (Fig. 8A and B). In contrast, Stx2
significantly cleaved procaspase 8 (P  0.001), with maximal
cleavage detected 8 h after toxin exposure (Fig. 8A and B).
Collectively, these data show that Stx1 and Stx2 may cleave
PARP independently of procaspase 3 cleavage. Furthermore,
Stx2 selectively activates caspase 8 in HK-2 cells.
DISCUSSION
Renal proximal epithelial cells express abundant Gb3 in
situ and have been implicated as targets of the action of Stxs.
For example, Karpman et al. used human renal cortical
FIG. 7. The ER stress response is differentially activated in HK-2 cells in response to Stx1 or Stx2 treatment. HK-2 cells were exposed to 75
pg/ml Stx1 or Stx2, and at the indicated time points, cells were lysed and whole-cell lysates (100 g/well) were subjected to SDS-PAGE (4% to
20%) and probed using antibodies specific for BiP (78 kDa) (A) and CHOP (28 kDa) (B). The blots shown are characteristic of three independent
experiments. The bar graphs depict fold changes derived from mean densitometric readings of Western blot band intensities from three
independent experiments. The data are expressed as means plus SEM, and statistical significance was calculated using one-way ANOVA. The
asterisks denote significant differences compared to control cells (*, P  0.05; **, P  0.01; ***, P  0.001; NS, not significant).
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epithelial cells and a renal carcinoma cell line to investigate
the cytotoxic effects of Stxs (23). Stxs induced apoptosis in
both cell types, as evidenced by nuclear fragmentation,
DNA laddering, and the presence of terminal deoxynucle-
otidyltransferase-mediated dUTP-biotin nick end labeling
(TUNEL)-positive cells. We showed that HK-2 cells main-
tain high levels of Gb3 expression in vitro and are sensitive
to Stx1 and Stx2. Given epidemiologic studies suggesting
that infections with Stx2-producing E. coli strains are more
likely to progress to DHUS (3, 24, 37), one might predict
that HK-2 cells would be more sensitive to Stx2. We found
the converse to be the case. HK-2 cells were sensitive to all
doses of Stx1 at all time points tested (CD50  0.1 pg/ml).
HK-2 cells were less sensitive to Stx2 and over time showed
an upward trend in CD50 values, suggesting that a subpop-
ulation of cells may have survived Stx2 exposure. Vero cells
are widely used as the prototypical cell type for defining Stx
cytotoxicity, and we compared Vero and HK-2 cell sensitiv-
ities to the toxins. The data highlight the importance of
establishing experimental parameters in determining CD50s.
At 24 h, HK-2 cells were significantly more sensitive to Stxs;
by 48 h, the cells displayed similar dose-dependent cytotox-
icity profiles; and at 72 h, Vero cell monolayers were com-
pletely destroyed while a subset of HK-2 cells appeared to
have survived Stx2 challenge. Histopathologic examination
of renal tissues from animals administered purified Stxs
showed evidence of renal tubule regeneration (51), and the
HK-2 cells that survived Stx2 challenge may represent this
subpopulation. Other cell types have displayed differential
sensitivity to Stxs. For example, Bauwens et al. (1) showed
that a cell line derived from human umbilical veins was 10
times more sensitive to killing by Stx1 than by Stx2, while
microvascular endothelial cells were more sensitive to kill-
ing by Stx2. There are a number of factors that may influ-
ence cell susceptibility to Stxs, including levels of Gb3 ex-
pression, biochemical characteristics of Gb3 (e.g., fatty acid
chain length and degree of hydroxylation), Gb3 presentation
at the membrane (e.g., lipid raft-associated expression), and
mechanisms of toxin internalization and intracellular rout-
ing. Fluorescently labeled Stx1 B subunits have been exten-
FIG. 8. Stx1 and Stx2 treatment induces caspase 3-independent PARP cleavage. (A) HK-2 cells were stimulated with 75 pg/ml Stx1 or Stx2, and
at the indicated time points, cells were lysed and whole-cell lysates (100 g/well) were subjected to SDS-PAGE (4% to 20%) and probed using
antibodies specific for cleaved PARP (c-PARP; 89 kDa), caspase 3 (17 kDa), and caspase 8 (43 kDa). The blots shown are characteristic of three
independent experiments. WB, Western blotting. (B) Fold changes in PARP and procaspase 8 cleavage derived from mean densitometric readings
of Western blot band intensities from three independent experiments. The data are expressed as means plus SEM, and statistical significance was
calculated using one-way ANOVA. The asterisks denote significant differences compared to control cells (*, P 0.05; **, P 0.01; ***, P 0.001;
NS, not significant). (C) HK-2 cells were stimulated with doxorubicin HCl as a positive control for apoptosis induction for 6 h, subjected to
SDS-PAGE, and probed using antibodies specific for caspase 3.
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sively employed to characterize Stx intracellular routing to
different cellular compartments (11, 14). We showed that B
subunits were routed to ER and lysosomal compartments in
HK-2 cells. Rapid transport to the ER, with maximal fluo-
rescence detected 60 min after Stx1 B subunit exposure,
correlates with the sensitivity of HK-2 cells to killing by Stxs.
The data showing that HK-2 cells route Stxs to lysosomes
suggest that the subpopulation of cells surviving toxin expo-
sure may direct a portion of internalized toxins into the
lysosomal degradation pathway.
Hughes et al. (18) noted that primary human renal prox-
imal tubule epithelial cells cultured in vitro for 24 h ex-
pressed basal levels of soluble TNF- and IL-1 (84.2 
 17.4
and 9.0 
 1.4 ng/mg, respectively). Incubation of the cells
with sublethal concentrations (0.01 to 0.1 pg/ml) of Stx1 for
4 h failed to increase cytokine expression above basal levels,
although exposure to Stx1 for 24 to 48 h resulted in 2- to
4-fold increases in TNF- and IL-1 protein expression. In-
creases in cytokine protein expression were accompanied by
greater increases in TNF- and IL-1 transcripts. We also
detected basal expression of soluble TNF- (2.0 pg/ml) in
supernatants collected from HK-2 cells. The treatment of
HK-2 cells with Stx1 or Stx2 for up to 4 h increased TNF-
and IL-1 transcript levels without concomitant significant
increases in protein expression. Thus, prior to the onset of
extensive cell death, neither primary cells nor HK-2 cells
appear to be significant producers of TNF- or IL-1 when
exposed to Stxs in vitro. Stxs did not appear to induce the
expression of the neutrophil chemoattractant IL-8. With the
exception of a single time point following exposure to Stx2
for 30 min, we did not detect significant elevations in IL-8
mRNA levels, and IL-8 protein levels were reduced, albeit
in a statistically nonsignificant manner, compared to basal
IL-8 expression. However, HK-2 cells released the macro-
phage chemoattractants MIP-1 and MIP-1 in response to
Stx2 treatment, but not in the presence of Stx1. Keepers et
al. (25) used a murine model of Stx-mediated renal damage
to show that macrophages were recruited to the kidneys of
mice injected with Stx2 with or without lipopolysaccharides
(LPS), in association with increased renal production of
chemoattractants, including MIP-1. Neutralizing antibod-
ies against MIP-1 decreased macrophage infiltration and
fibrin deposition within the renal vasculature. These findings
suggest a role for infiltrating macrophages in DHUS but
do not clarify which cell type(s) secretes chemokines in
response to Stxs. Our data suggest that Stx2 is uniquely
capable of triggering the production and release of MIP-1
and MIP-1, and localized upregulation of chemokine pro-
duction may facilitate the recruitment of activated immune
cells, such as macrophages, into sites of initial tissue dam-
age. HK-2 cells express tissue factor constitutively, and Stx1
induces the expression of cell surface tissue factor in a dose-
and time-dependent manner (35). Toxin-mediated renal tu-
bular damage may activate the coagulation system, leading
to the formation of platelet-fibrin microthrombi. Macro-
phages and macrophage cell lines are known to produce
tissue factor and cytokines in response to Stxs (34). Thus,
infiltrating macrophages may further exacerbate inflamma-
tion, thrombogenesis, and tissue damage.
The mechanism(s) by which Stxs induce apoptosis in
HK-2 cells has not been well characterized. Wilson et al.
(56) showed that HK-2 cells were sensitive to Stx2, under-
going apoptosis, as assessed by PARP cleavage and nuclear
fragmentation. The silencing of expression of the proapop-
totic factor Bak decreased PARP cleavage and protected
HK-2 cells from apoptosis, suggesting that Stxs trigger sig-
naling through the intrinsic or mitochondrion-mediated
apoptosis pathway. Stxs induce apoptosis in the THP-1 cell
line through activation of the UPR and prolonged ER stress
signaling (31). The ER is the site of protein folding and
posttranslational modification, trafficking of proteins to var-
ious locations, and intracellular Ca2 storage (2, 41). Pro-
tein folding and processing are monitored by a series of
“folding sensors” localized within the ER membrane: the
transcriptional activator ATF6, the serine/threonine kinase
PERK, and the kinase/endoribonuclease IRE1. The chap-
erone BiP dissociates from the sensors in the presence of
unfolded or misfolded proteins, leading to kinase dimeriza-
tion and activation and the transit of ATF6 to the Golgi
apparatus for proteolysis and activation. The activated sen-
sors initiate the UPR, a coordinated series of signaling
events involving the attenuation of translation and the tran-
scriptional activation of genes encoding proteins involved in
protein folding and degradation. Thus, the UPR may result
in decreased de novo protein synthesis and clearance of
unfolded proteins from the ER lumen (41). However, pro-
longed UPR signaling leads to ER stress and the induction
of apoptosis (4, 41). Therefore, we examined the capacity of
Stxs to induce ER stress in HK-2 cells. Stx1 and Stx2 acti-
vated different and nonoverlapping UPR sensors. Stx1 in-
duced ATF6 cleavage from the inactive 90-kDa form to the
active 50-kDa fragment. Stx2 triggered the phosphorylation
of the sensors PERK and IRE1. Signaling for increased
expression of the chaperone BiP appeared to be correlated
with ATF6 activation, as Stx1 transiently, but significantly,
upregulated BiP expression. ER stress-induced apoptosis is
mediated in large part by the transcriptional factor CHOP.
The ability of CHOP to induce apoptosis is dependent on
the duration and degree of ER stress (19). CHOP is acti-
vated through PERK and ATF6 signaling and induces the
expression of several proapoptotic factors. Stx1 induced a
9-fold increase in CHOP expression 1 h after intoxication
compared to a 2.5-fold maximal increase in HK-2 cells ex-
posed to Stx2. Thus, the increased sensitivity of HK-2 cells
to Stx1 appears to be correlated with the effective activation
of ATF6, leading to enhanced signaling through CHOP,
while HK-2 cell survival following Stx2 challenge may be
related to reduced ATF6 activation and the transient acti-
vation of ER stress. Additional studies will be required to
explore the role of ER stress in HK-2 cell death and survival.
Despite differences in the ER stress response, both toxins
triggered PARP cleavage. Caspase 3 is the major execu-
tioner caspase involved in PARP cleavage, and several stud-
ies have shown that Stxs activate caspase 3 in epithelial cells
and cell lines (50). Thus, our inability to detect procaspase
3 cleavage in HK-2 cells treated with Stxs was unexpected.
Calpains may cleave PARP in the absence of caspase acti-
vation (55), and preliminary data from our laboratory sug-
gest that both Stx1 and Stx2 activate calpains in HK-2 cells.
PARP may also be activated by proapoptotic mitochondrial
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intermembrane proteins released following the disruption of
mitochondrial membranes, including apoptosis-inducing
factor and endonuclease G (8). Stxs activate apoptotic sig-
naling through the rapid activation of caspase 8 in several
different cell types (13, 30). Our data suggest that Stx2
cleaves procaspase 8 in HK-2 cells while Stx1 fails to do so.
Stx-induced activation of caspase 8 may lead to the activa-
tion of the Bcl-2 protein family member BID, which in turn
translocates to the mitochondria to facilitate mitochondrial-
membrane depolarization and the release of mitochondrial
intermembrane constituents into the cytoplasm (29). These
events trigger the formation of the apoptosome and the
activation of procaspase 9, and caspase 9 then activates
caspase 3. We detected minimal caspase 3 generation in
Stx-treated HK-2 cells. Precisely how caspase 3 activation is
disrupted is not known, but Fujii et al. (12) showed that Stx
treatment of HeLa cells resulted in increased expression of
XIAP, which blocks caspase 3 activation. Whether a similar
pathway limiting apoptosis induction is operative in HK-2
cells requires additional scrutiny.
We used results gathered from in vitro and in vivo studies
to derive a model for the role of renal epithelial cells in the
pathogenesis of disease caused by STEC (Fig. 9). Following
adherence to colonic epithelial cells, the bacteria produce
Stxs (Fig. 9A). LPS from STEC (or from other intestinal
flora) may gain access to the submucosa, as patients with
STEC infections frequently possess elevated anti-STEC O-
antigen antibody titers (38). Once within the lamina propria,
the toxins encounter resident tissue macrophages and neu-
trophils (Fig. 9B). Toxin interaction with macrophages elic-
its the rapid expression and secretion of proinflammatory
cytokines and chemokines (15, 16). TNF- and IL-1 se-
creted by macrophages may exacerbate Stx-induced damage
to colonic capillaries, releasing blood into the lumen of the
intestine and creating portals of entry for Stxs and LPS into
the bloodstream (Fig. 9C). Toxin binding to neutrophils may
facilitate hematogenous spread and access to target organs
(Fig. 9B and D) (5). The toxins may access the renal tubular
epithelium via blood vessels supplying the tubules, although
the precise mechanism is not known. Based on data pre-
sented here, Stx2 may selectively induce the expression of
the chemokines MIP-1 and MIP-1 by proximal tubules of
the human kidney (Fig. 9E). These chemokines recruit mac-
rophages to sites of injury. Infiltrating macrophages may
FIG. 9. Potential role of human proximal tubule epithelial cells in the pathogenesis of hemolytic uremic syndrome. (A) STEC adheres to the
colonic epithelium. (B) The bacteria produce and release Stxs (green), which may gain access to the submucosa via transcytotic or paracellular
mechanisms. (C) Stxs are internalized by resident tissue macrophages, inducing the production and secretion of proinflammatory cytokines and
chemokines. Simultaneously, Stxs bind to and “piggyback” on neutrophils through circulation. (D) TNF- and IL-1 upregulate expression of the
Stx receptor on endothelial cells, resulting in increased vascular damage and systemic transport of Stxs in the blood. (E) Once in circulation, Stxs
target the renal epithelium, which is rich in membrane-bound Gb3. Renal proximal tubular epithelial cells are damaged, but a subpopulation of
cells survive and, in response to Stx2, secrete both MIP-1 and MIP-1, which in turn recruit inflammatory cells, such as macrophages and
neutrophils, to sites of damage. (F) Activated macrophages secrete TNF- and IL-1, further sensitizing the microvascular endothelial cells.
(G) Fibrin deposits build up in the microvasculature of the kidney, trapping circulating red blood cells and platelets. (Figure adapted from Medical
Illustrations, Michal Komorniczak, with permission.)
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produce cytokines and sensitize glomerular endothelial cells
to Stxs by upregulating expression of membrane-bound Gb3
(Fig. 9F). Microvascular damage progresses to the forma-
tion of fibrin deposits, which bind circulating red blood cells
and platelets, leading to hemolytic anemia and thrombocy-
topenia (Fig. 9G).
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